BCR and Autoimmunity: Collectively, these data demonstrate that Gal9 regulates BCR-driven and unique TLR-driven B-1a responses by regulating the association of these receptors with negative co-receptors, loss of which enhances B-1a-derived antibody production and consequently autoantigen delivery to splenic B cells to drive autoimmunity.